首页> 美国卫生研究院文献>other >Clinical effectiveness and cost-effectiveness of first-line chemotherapy for adult patients with locally advanced or metastatic non-small cell lung cancer: a systematic review and economic evaluation.

【2h】

Clinical effectiveness and cost-effectiveness of first-line chemotherapy for adult patients with locally advanced or metastatic non-small cell lung cancer: a systematic review and economic evaluation.

机译：一线化疗对局部晚期或转移性非小细胞肺癌成年患者的临床疗效和成本效益：系统评价和经济评价。

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BACKGROUNDThe National Institute for Health and Care Excellence (NICE) has issued multiple guidance for the first-line management of patients with lung cancer and recommends different combinations of chemotherapy treatments. This review provides a synthesis of clinical effectiveness and cost-effectiveness evidence supporting current guidance.

机译：背景美国国立卫生研究院（NICE）已针对肺癌患者的一线治疗发布了多份指南，并推荐了不同的化学疗法组合。这篇综述提供了支持当前指南的临床有效性和成本效益证据的综合。

著录项

期刊名称 other
作者
T Brown; G Pilkington; A Bagust; A Boland; J Oyee; C Tudur-Smith; M Blundell; M Lai; C Martin Saborido; J Greenhalgh; Y Dundar; R Dickson;
展开▼
作者单位

展开▼
年(卷),期 -1(17),31
年度 -1
页码 1–278
总页数 17
原文格式 PDF
正文语种
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Clinical effectiveness and cost-effectiveness of first-line chemotherapy for adult patients with locally advanced or metastatic non-small cell lung cancer: a systematic review and economic evaluation [J] . Health technology assessment: HTA . 2013,第31期

机译：一线化疗对局部晚期或转移性非小细胞肺癌成年患者的临床疗效和成本效益：系统评价和经济评价
2. A systematic review of the clinical effectiveness of first-line chemotherapy for adult patients with locally advanced or metastatic non-small cell lung cancer [J] . Pilkington Gerlinde, Boland Angela, Brown Tamara, Thorax: The Journal of the British Thoracic Society . 2015,第4期

机译：一线化疗对局部晚期或转移性非小细胞肺癌成年患者临床疗效的系统评价
3. Clinical Effectiveness and Cost-effectiveness of Target Therapies for Adult Patients with Locally Advanced or Metastatic Non-small Cell Lung Cancer: A Systematic Review [J] . Bearz Alessandra, Berretta Massimiliano, Tirelli Umberto Current cancer drug targets . 2018,第5期

机译：局部晚期或转移性非小细胞肺癌成人患者靶疗法的临床效果和成本效益：系统审查
4. The clinical efficacy of transfusion of cytokine-induced killer cells combined with chemotherapy and XiaoJi decoction in patients with stage IIIB/IV non-small cell lung cancer [C] . Liuning Li, Jiaying Liu, Xiaoshu Chai, IEEE International Conference on Bioinformatics and Biomedicine . 2014

机译：细胞因子诱导的杀伤细胞输注结合化学疗法和消积汤治疗IIIB / IV期非小细胞肺癌的临床疗效
5. Assessing the effectiveness of palliative chemotherapy for non-small cell lung cancer: A phase IV study of patients treated at Ontario's cancer centres [D] . Harrison, Lyndsay Dawn. 2012

机译：评估姑息化疗对非小细胞肺癌的有效性：在安大略省癌症中心接受治疗的患者的IV期研究
6. Clinical effectiveness of first-line chemoradiation for adult patients with locally advanced non-small cell lung cancer: a systematic review. [O] . T Brown, G Pilkington, A Boland, -1

机译：一线放化疗的成年患者的临床疗效与局部晚期非小细胞肺癌的系统评价。
7. A systematic review of the clinical effectiveness of first-line chemotherapy for adult patients with locally advanced or metastatic non-small cell lung cancer [O] . G. Pilkington, A. Boland, T. Brown, 2015

机译：局部晚期或转移性非小细胞肺癌成人患者一线化疗的临床效果系统综述

Clinical effectiveness and cost-effectiveness of first-line chemotherapy for adult patients with locally advanced or metastatic non-small cell lung cancer: a systematic review and economic evaluation.

摘要

著录项

相似文献

相关主题

期刊订阅